Lantheus
Website to be confirmed.
About Lantheus
Lantheus is a Radiopharma Developer company; the kind of vendor BD teams should have a 15-minute conversation with at SNMMI.
Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.
What we're seeing
- STAT News · 2026-08-17Lantheus partners with academic center on Actinium-225 programIndustry observers expect more activity of this kind in the run-up to SNMMI 2026.
- Imaging Wire · 2026-11-10Lantheus files IND for next-generation PSMA-targeted agentThe announcement comes amid tightening Mo-99 and Lu-177 supply.
- PR Newswire · 2026-02-03Lantheus publishes dosimetry data at SNMMI 2026Coverage notes the company's growing footprint in the radioligand therapy space.
Mocked while we wire the Exa integration. Headlines are illustrative.
What we expect to see at the booth
Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.
A short Bracken POV will go here, drawing on our experience across this part of the radiopharma value chain. Specific commentary to be filled in by the team.
Editorial shown for exhibitors in Bracken's wheelhouse: radiopharma developers, isotope supply, CDMO/CMO, cyclotron, and imaging equipment.
Companies you may also want to visit.
Actinium Pharmaceuticals
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Actinium Pharmaceuticals.
View profile →AtomVie Global Radiopharma Inc.
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on AtomVie Global Radiopharma Inc..
View profile →Bayer Oncology
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Bayer Oncology.
View profile →